Background technology
Avermectins medicine comprises: ivermectin Ivermectin, avilamycin Avermectin, Eprinomectin Eprinomectin, doractin Doramectin, milbemycin oxime Milbemycin Oxime, moxidectin Moxidectin.These Avermectins medicines are mainly used in preventing and treating nematicide and the epizootic disease of the animals such as pig, cattle, sheep at veterinary clinic, their " character, pharmacology and purposes " etc. are < < veterinary drug handbook > > (Zhu Mozhong chief editor, Chemical Industry Press, July in 2002 the 1st edition, 167-174 page) all on the books and describe and in open source literature.Containing the commercially available injection of Avermectins medicine, majority is to be solution type preparation prepared by solvent with organic solvent (as 1,2-PD, N-Methyl pyrrolidone, formal glycerine etc.) or the grease compounds of synthetic; The disclosed injection containing Avermectins medicine of document or patent has solution type preparation, suspension type preparation, Emulsion, have containing microsphere or microcapsule or containing the long-acting injection of different slow-released carriers (as polyvinylpyrrolidone, polylactic acid, PLGA, Sucrose acetoisobutyrate, castor oil hydrogenated, Semen Ricini wet goods).The long-acting injection of containing hydrogenated Oleum Ricini mainly contains: castor oil hydrogenated and Avermectins medicine are prepared into solid dispersion, suspend in water or the complex media of water and 1,2-PD in, or be suspended in dimethyl-silicon wet goods oil medium; Also have castor oil hydrogenated is dissolved in and in oil medium, prepares slow releasing injection.
Injection of the present invention and technology of preparing thereof are different from published injection and technology of preparing thereof containing Avermectins medicine, feature of the present invention is: Avermectins medicine/HCO medicine carrying microgranule is suspended in the P407 aqueous solution of 18-22%, be prepared into the in-situ gelling injection containing Avermectins medicine/HCO medicine carrying microgranule, after this preparation injects in animal body, under body temperature effect, P407 is converted into gel by colloidal sol, Avermectins medicine/HCO medicine carrying microgranule is wrapped in by gel lump, medicine need slowly decompose just and can complete dispose procedure with the slow dissolving of gel and HCO.Therefore, this preparation is different from the simple in-situ gelling injection containing P407, is also different from the simple slow releasing injection containing HCO solid dispersion.
This process for preparation of injection is simple, and release is even, and single administration reaches 95% or higher for preventing and treating pig, cattle, sheep nematicide and ectoparasite disease effective percentage, effectively sustainable 60 days of drug release time or longer.This injection good biocompatibility, to the tissue of injection site without irreversible damage, slow-released carrier degradable and excretion used.
Summary of the invention
1. preparation forms:
This preparation comprises Avermectins medicine, P407, HCO and water; HCO and Avermectins medicine are prepared to medicine carrying microgranule, with medicine carrying microgranule state, are suspended in P407 aqueous solution, are prepared into in-situ gelling injection.
In every liter of injection, containing Avermectins medicine/HCO medicine carrying microgranule 50-150g, P407180-220g, water for injection adds to 1 liter; In medicine carrying microgranule, the weight ratio of Avermectins medicine and HCO is 1: 0.5-1.
In above-described every liter of injection, can also add hydroxypropyl emthylcellulose (HPMC) 10-30g.
In above-described every liter of injection, can also add 5-10g PLURONICS F87 (P188).
2. preparation method:
(1) by HCO and Avermectins medicine in low boiling point organic solvent (low boiling point organic solvent comprises: methanol, ethanol, ethyl acetate, acetone, chloroform), reflux is treated to dissolve completely, do not stopping under stirring, removal of solvent under reduced pressure, obtain solids, solids is pulverized, crossed 40 mesh sieves, obtain Avermectins medicine/HCO medicine carrying microgranule.
(2) will be about medicine carrying microgranule weight 1.5-2 P407 aqueous solution doubly (containing P407 approximately 10%; weight/volume) mix with medicine carrying microgranule; crossing high-shear homogenizing machine (15000-17000rpm) homogenizes; with colloid mill, be ground to particle diameter afterwards and be less than 80 μ m; with sand mill, be ground to particle diameter again and be less than 30 μ m; add residue composition; after homogenizing with homogenizer; degassed under 5-15 ℃, negative pressure 0.06-0.08mpa condition, must be containing the in-situ gelling injection of Avermectins medicine/HCO medicine carrying microgranule.
The specific embodiment
Embodiment 1,10% avilamycin in-situ gelling injection preparation
Preparation forms: every liter of preparation adds to 1 liter containing avilamycin/HCO (weight ratio is 1: 0.5) medicine carrying microgranule 150g, P407180g, water for injection.
Preparation method: (1) by castor oil hydrogenated in 90-95 ℃ of thawing, be cooled to 70 ℃ of left and right, add avilamycin and appropriate ethanol, reflux avilamycin is dissolved completely, afterwards at stirring condition borehole cooling to 40-55 ℃, distilling under reduced pressure, Ex-all ethanol, obtains solids, pulverizes, cross 40 mesh sieves, obtain avilamycin/HCO medicine carrying microgranule.(2) the 10%P407 aqueous solution with appropriate (being about the 1.5-2 of medicine carrying microgranule amount doubly) by medicine carrying microgranule, cross high-shear homogenizing machine and shear 3-5 time, with colloid mill, be ground to particle diameter afterwards and be less than 80 μ m, then with sand mill, be ground to particle diameter and be less than 20 μ m, obtain dense thick suspension.(3) in suspension, add remaining P407 aqueous solution, after homogenizing with homogenizer, degassed under 5-15 ℃, negative pressure 0.06-0.08mpa condition, must be containing the in-situ gelling injection of avilamycin/HCO medicine carrying microgranule.
Embodiment 2,7% ivermectin in-situ gelling injection preparation
Ivermectin/HCO (weight ratio is 1: 1) medicine carrying microgranule 140g, P407180g, water for injection add to 1 liter.
Preparation method: (1) by castor oil hydrogenated in 90-95 ℃ of thawing, be cooled to 70C left and right, add ivermectin and the suitable ethanol of ivermectin triplication, reflux ivermectin is dissolved completely, afterwards at stirring condition borehole cooling to 40-55 ℃, distilling under reduced pressure, Ex-all ethanol, obtains solids, pulverizes, cross 40 mesh sieves, obtain ivermectin/HCO medicine carrying microgranule.(2) the 10%P407 aqueous solution with appropriate (being about the 1.5-2 of medicine carrying microgranule amount doubly) by medicine carrying microgranule, cross high-shear homogenizing machine and shear 3-5 time, with colloid mill, be ground to particle diameter afterwards and be less than 80 μ m, then with sand mill, be ground to particle diameter and be less than 20 μ m, obtain dense thick suspension.(3) in suspension, add remaining P407 aqueous solution, after homogenizing with homogenizer, degassed under 5-15 ℃, negative pressure 0.06-0.08mpa condition, must be containing the in-situ gelling injection of ivermectin/HCO medicine carrying microgranule.
Embodiment 3,5% doramectin in-situ gelling injection preparation
Doramectin/HCO (weight ratio is 1: 0.8) medicine carrying microgranule 90g, P407200g, water for injection add to 1 liter.
Embodiment 4,7.5% Eprinomectin injection
Eprinomectin/HCO (weight ratio is 1: 1) medicine carrying microgranule 150g, P407180g, P18810g, HPMC22g, water for injection adds to 1 liter.
Embodiment 5,5% ivermectin in-situ gelling injection preparation
Ivermectin/HCO (weight ratio is 1: 1) medicine carrying microgranule 50g, ivermectin/HCO (weight ratio is 1: 0.5) medicine carrying microgranule 37.5g, P407180g, P18810g, HPMC20g, glycerol 65g, water for injection adds to 1 liter.
Injection described in above embodiment 3 to embodiment 5, preparation method is with embodiment 1.
Embodiment 6, the embodiment 5 preparations blood drug level in sheep body detects
Experimental animal grouping and result of the test: select 9 of healthy sheep, be divided into 3 groups, every group 3, cervical region subcutaneous injection embodiment 5 preparations, dosage is respectively 0.5mg/kg b.w. (A group), 0.8mg/kg b.w. (B group), 1.2mg/kg b.w. (C group), blood sampling on time, separated plasma, and after the plasma sample of same time is on the same group mixed with acetonitrile extraction, through centrifugal, purify (C
18post), the process such as concentrated, derivatization, make detection sample, adopt ivermectin content in HPLC (fluorescence detector) working sample.
Testing result is as shown in the table:
More than in table, numerical value is the meansigma methods of every group of 3 sheep blood plasma drug level.